|
|
Post by selluwud on Jan 9, 2015 13:59:21 GMT
|
|
|
|
Post by Yelk on Jan 9, 2015 14:25:04 GMT
Probably need to have been in 1.5 hours ago  Doesn't mean it won't go thumbs up strong just more risk for large downside. It was on my watch list today as well - missed the train. |
|
|
|
Post by selluwud on Jan 14, 2015 13:30:47 GMT
I have been looking at the chart here and see several gaps in the chart over the last 3 months. Not sure how far back they may fill, but the 2nd gap back looks interesting. Jan 8th to 9th there was a gap of 4.11 to 4.88. I may try to enter somewhere in that space.
|
|
|
|
Post by selluwud on Oct 27, 2015 12:28:00 GMT
I bought some AGEN in September at 4.49 after selling my ONCS when it was falling. They had so many products in the pipeline and the price was at a low so it seemed to be good investment. I have to admit I was influenced by an investment analysis piece I happened across even though those aren't always necessarily good advice. Nice activity this AM after a shingles vaccine trial by GSK was announced showing promise using the AGEN adjuvant QS-21.
|
|
|
|
Post by selluwud on Jun 9, 2016 13:08:32 GMT
I bought some AGEN in September at 4.49 after selling my ONCS when it was falling. They had so many products in the pipeline and the price was at a low so it seemed to be good investment. I have to admit I was influenced by an investment analysis piece I happened across even though those aren't always necessarily good advice. Nice activity this AM after a shingles vaccine trial by GSK was announced showing promise using the AGEN adjuvant QS-21. I got rid of this the last time it crossed my entry point and neither lost nor gained. Maybe I should have held for today's announcement though I don't expect a large run up. My typical investment results repeat themselves again. LOL finance.yahoo.com/news/agenus-announces-lead-product-candidate-125000128.html |
|
Doesn't mean it won't go thumbs up strong just more risk for large downside. It was on my watch list today as well - missed the train.